ACAD Drug To Be in Europe, Us and Many Other Countries. read
(( Thank you previous poster..this is really great info. I wondered if they would yake this outside US and they are which makes this stock much more valuable.))
This was copied and pasted from ACAD Homepage Website:
We hold worldwide rights to pimavanserin and have established a patent portfolio, which includes numerous issued patents covering pimavanserin in the United States, Europe and several additional countries.
We believe that pimavanserin also has the potential to address a range of other neurological and psychiatric disorders that are under served by currently available anti psychotics and represent large unmet medical needs. This may include treatment for psychoses associated with other neurological disorders, including Alzheimer’s disease, and as a co-therapy for schizophrenia